AN UNBIASED VIEW OF PROSTATE CANCER TREATMENT NIGERIA

Little clinical trials comparing them head-to-head at the different levels of prostate cancer could well be desired. This may be performed with asymptomatic Gentlemen who may have early State-of-the-art-stage prostate cancer (e.g. PSA > 60 ng/ml); a downward change of PSA can be easily utilized as a applicable biomarker endpoint in rather smaller a